Advertisement
ACRS vs STRRP
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Buy and STRRP is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ACRS’s FA Score shows that 1 FA rating(s) are green whileSTRRP’s FA Score has 1 green FA rating(s).
- ACRS’s FA Score: 1 green, 4 red.
- STRRP’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ACRS’s TA Score shows that 4 TA indicator(s) are bullish while STRRP’s TA Score has 4 bullish TA indicator(s).
- ACRS’s TA Score: 4 bullish, 4 bearish.
- STRRP’s TA Score: 4 bullish, 5 bearish.
Price Growth
ACRS (@Biotechnology) experienced а +8.81% price change this week, while STRRP (@Other Consumer Services) price change was +1.64% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.
The average weekly price growth across all stocks in the @Other Consumer Services industry was -3.10%. For the same industry, the average monthly price growth was +9.65%, and the average quarterly price growth was -0.68%.
Reported Earning Dates
ACRS is expected to report earnings on Nov 05, 2025.
Industries' Descriptions
@Biotechnology (+2.52% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Other Consumer Services (-3.10% weekly)Other consumer services include companies that provide consumer services, and are not classified elsewhere. Travel fare aggregators, hotel bookings, consumer-to-consumer or business-to-business sales platforms are some examples of services that can be clubbed into this category. Many of such services have expanded online. Booking Holdings Inc, The Priceline Group Inc, and eBay Inc. are some major operators in this segment.
| ACRS | STRRP | ACRS / STRRP | |
| Capitalization | 227M | N/A | - |
| EBITDA | -57.87M | N/A | - |
| Gain YTD | -15.323 | 4.260 | -360% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 16.8M | N/A | - |
| Total Cash | 99.8M | N/A | - |
| Total Debt | N/A | N/A | - |
ACRS | STRRP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 47 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 24 Undervalued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 81 | |
SMR RATING 1..100 | 99 | 100 | |
PRICE GROWTH RATING 1..100 | 38 | 56 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
STRRP's Valuation (4) in the null industry is in the same range as ACRS (24) in the Pharmaceuticals Other industry. This means that STRRP’s stock grew similarly to ACRS’s over the last 12 months.
STRRP's Profit vs Risk Rating (81) in the null industry is in the same range as ACRS (100) in the Pharmaceuticals Other industry. This means that STRRP’s stock grew similarly to ACRS’s over the last 12 months.
ACRS's SMR Rating (99) in the Pharmaceuticals Other industry is in the same range as STRRP (100) in the null industry. This means that ACRS’s stock grew similarly to STRRP’s over the last 12 months.
ACRS's Price Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as STRRP (56) in the null industry. This means that ACRS’s stock grew similarly to STRRP’s over the last 12 months.
ACRS's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as STRRP (100) in the null industry. This means that ACRS’s stock grew similarly to STRRP’s over the last 12 months.
| ACRS | STRRP | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 80% | 3 days ago 50% |
| Stochastic ODDS (%) | 3 days ago 81% | 3 days ago 54% |
| Momentum ODDS (%) | 3 days ago 81% | 3 days ago 47% |
| MACD ODDS (%) | 3 days ago 78% | 3 days ago 52% |
| TrendWeek ODDS (%) | 3 days ago 81% | 3 days ago 42% |
| TrendMonth ODDS (%) | 3 days ago 81% | 3 days ago 38% |
| Advances ODDS (%) | 3 days ago 80% | 19 days ago 51% |
| Declines ODDS (%) | 20 days ago 85% | N/A |
| BollingerBands ODDS (%) | 3 days ago 79% | 3 days ago 40% |
| Aroon ODDS (%) | 3 days ago 85% | 3 days ago 50% |
Advertisement
ACRS and
Correlation & Price change
A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with PLLWF. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then PLLWF could also see price increases.
| Ticker / NAME | Correlation To ACRS | 1D Price Change % | ||
|---|---|---|---|---|
| ACRS | 100% | +1.45% | ||
| PLLWF - ACRS | 64% Loosely correlated | N/A | ||
| STRRP - ACRS | 52% Loosely correlated | N/A | ||
| MYNZ - ACRS | 40% Loosely correlated | -2.98% | ||
| UFPT - ACRS | 39% Loosely correlated | -0.75% | ||
| IBRX - ACRS | 34% Loosely correlated | +0.42% | ||
More | ||||
STRRP and
Correlation & Price change
A.I.dvisor indicates that over the last year, STRRP has been closely correlated with CVRX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRRP jumps, then CVRX could also see price increases.
| Ticker / NAME | Correlation To STRRP | 1D Price Change % | ||
|---|---|---|---|---|
| STRRP | 100% | N/A | ||
| CVRX - STRRP | 67% Closely correlated | +1.56% | ||
| ACRS - STRRP | 52% Loosely correlated | +1.45% | ||
| ANGO - STRRP | 48% Loosely correlated | N/A | ||
| ELUT - STRRP | 46% Loosely correlated | -6.47% | ||
| ZIMV - STRRP | 46% Loosely correlated | -0.16% | ||
More | ||||